Payments to Acquire Property, Plant, and Equipment of NEKTAR THERAPEUTICS from 31 Mar 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
NEKTAR THERAPEUTICS annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Mar 2010 to 31 Dec 2025.
  • NEKTAR THERAPEUTICS Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $2,000.
  • NEKTAR THERAPEUTICS annual Payments to Acquire Property, Plant, and Equipment for 2025 was $171,000, a 88% decline from 2024.
  • NEKTAR THERAPEUTICS annual Payments to Acquire Property, Plant, and Equipment for 2024 was $1,468,000, a 70% increase from 2023.
  • NEKTAR THERAPEUTICS annual Payments to Acquire Property, Plant, and Equipment for 2023 was $865,000, a 85% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

NEKTAR THERAPEUTICS Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $171,000 -$1,297,000 -88% 01 Jan 2025 31 Dec 2025 10-K 13 Mar 2026 2025 FY
2024 $1,468,000 +$603,000 +70% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2026 2025 FY
2023 $865,000 -$4,811,000 -85% 01 Jan 2023 31 Dec 2023 10-K 14 Mar 2025 2024 FY
2022 $5,676,000 -$9,313,000 -62% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2024 2023 FY
2021 $14,989,000 +$7,731,000 +107% 01 Jan 2021 31 Dec 2021 10-K 05 Mar 2024 2023 FY
2020 $7,258,000 -$19,027,000 -72% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $26,285,000 +$12,046,000 +85% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $14,239,000 +$4,563,000 +47% 01 Jan 2018 31 Dec 2018 10-K 26 Feb 2021 2020 FY
2017 $9,676,000 +$3,284,000 +51% 01 Jan 2017 31 Dec 2017 10-K 28 Feb 2020 2019 FY
2016 $6,392,000 -$4,803,000 -43% 01 Jan 2016 31 Dec 2016 10-K 01 Mar 2019 2018 FY
2015 $11,195,000 +$1,219,000 +12% 01 Jan 2015 31 Dec 2015 10-K 01 Mar 2018 2017 FY
2014 $9,976,000 +$5,885,000 +144% 01 Jan 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
2013 $4,091,000 -$6,492,000 -61% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
2012 $10,583,000 +$861,000 +8.9% 01 Jan 2012 31 Dec 2012 10-K 26 Feb 2015 2014 FY
2011 $9,722,000 -$21,735,000 -69% 01 Jan 2011 31 Dec 2011 10-K 27 Feb 2014 2013 FY
2010 $31,457,000 01 Jan 2010 31 Dec 2010 10-K 01 Mar 2013 2012 FY

NEKTAR THERAPEUTICS Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $2,000* -$155,000 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q1 2024 $157,000 -$276,000 -64% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025 2025 Q1
Q1 2023 $433,000 -$3,770,000 -90% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q1 2022 $4,203,000 +$1,327,000 +46% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q1 2021 $2,876,000 +$1,976,000 +220% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q1 2020 $900,000 -$4,748,000 -84% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021 2021 Q1
Q1 2019 $5,648,000 +$4,663,000 +473% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q1 2018 $985,000 -$3,104,000 -76% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q1 2017 $4,089,000 +$2,410,000 +144% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q1 2016 $1,679,000 +$620,000 +59% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q1 2015 $1,059,000 -$3,465,000 -77% 01 Jan 2015 31 Mar 2015 10-Q 04 May 2016 2016 Q1
Q1 2014 $4,524,000 +$4,208,000 +1332% 01 Jan 2014 31 Mar 2014 10-Q 01 May 2015 2015 Q1
Q1 2013 $316,000 -$1,200,000 -79% 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014 2014 Q1
Q1 2012 $1,516,000 -$2,249,000 -60% 01 Jan 2012 31 Mar 2012 10-Q 09 May 2013 2013 Q1
Q1 2011 $3,765,000 -$208,000 -5.2% 01 Jan 2011 31 Mar 2011 10-Q 04 May 2012 2012 Q1
Q1 2010 $3,973,000 01 Jan 2010 31 Mar 2010 10-Q 29 Apr 2011 2011 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.